Table 2.
Adverse Events in 6-month Study Period by Rural or Urban Designation
Event | Rural | Urban | Χ2 | p-value |
---|---|---|---|---|
Major Infection | 13 | 44 | 0.14 | 0.93 |
Bleeding | 9 | 23 | 0.48 | 0.79 |
Device Thrombosis | 7 | 19 | 2.76 | 0.43 |
Neurologic Dysfunction | 5 | 20 | 2.25 | 0.52 |
Major Infection: driveline, sternal wounds, and/or pump pocket
Bleeding: gastrointestinal, epistaxis, intracranial, and/or subconjunctival hemorrhage
Device Thrombosis: confirmed or suspected pump thrombosis
Neurologic Dysfunction: confusion, cognitive changes, tremor, stroke